T-cell phenotypes, apoptosis and inflammation in HIV+ patients on virologically effective cART with early atherosclerosis
about
START or SMART? Timing of Antiretroviral Therapy Initiation and Cardiovascular Risk for People With Human Immunodeficiency Virus InfectionPro-Inflammatory Markers in Relation to Cardiovascular Disease in HIV Infection. A Systematic ReviewInitiation of antiretroviral therapy at high CD4 cell counts: does it reduce the risk of cardiovascular disease?Polyclonal antithymocyte globulin and cardiovascular disease in kidney transplant recipientsMicrobial translocation and cardiometabolic risk factors in HIV infection.Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection.Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial.Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment.Invariant natural killer T (iNKT) cells in HAART-treated, HIV-positive patients with bone and cardiovascular impairment.Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis.Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring?Decreased naive and increased memory CD4(+) T cells are associated with subclinical atherosclerosis: the multi-ethnic study of atherosclerosis.Cardiovascular disease risk in an aging HIV population: not just a question of biology.Relationships of pulmonary function, inflammation, and T-cell activation and senescence in an HIV-infected cohortHigher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients.Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral Therapy.The Association of Human Cytomegalovirus with Biomarkers of Inflammation and Immune Activation in HIV-1-Infected Women.CD4+/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapyInflammation, immune activation, and cardiovascular disease in HIV.Pathophysiology and management of cardiovascular disease in patients with HIVMaraviroc Intensification Improves Endothelial Function in Abacavir-Treated Patients, an Open-Label Randomized Cross-Over Pilot StudyRole of T-Cell Dysfunction, Inflammation, and Coagulation in Microvascular Disease in HIV.From "truly naïve" to "exhausted senescent" T cells: when markers predict functionality.Inflammatory co-morbidities in HIV+ individuals: learning lessons from healthy ageing.Risk of coronary heart disease in patients with HIV infection.Emerging Role and Characterization of Immunometabolism: Relevance to HIV Pathogenesis, Serious Non-AIDS Events, and a Cure.Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individuals.HIV-1-Associated Atherosclerosis: Unraveling the Missing Link.Greater carotid intima media thickness at a younger age in HIV-infected patients compared with reference values for an uninfected cohort.Subclinical atherosclerosis in low Framingham risk HIV patients.Association of Macrophage Inflammation Biomarkers With Progression of Subclinical Carotid Artery Atherosclerosis in HIV-Infected Women and Men.Determinants of a Low CD4/CD8 Ratio in HIV-1-Infected Individuals Despite Long-term Viral Suppression.Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients.Associations between surface markers on blood monocytes and carotid atherosclerosis in HIV-positive individuals.Low levels of endothelial progenitor cells and their association with systemic inflammation and monocyte activation in older HIV-infected men.Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4+ T Cell Restoration.
P2860
Q26753830-CB8F1235-87AB-48D3-AC32-0BEA7DA368CDQ26774828-D0154691-9962-45CE-9335-7DE02EC59A67Q33649200-5B215BBD-2278-4ABF-9949-FBBF22419090Q33660602-24EE79CA-0656-46BA-84A5-2E1C2F936AFEQ33713895-FE89A876-D494-4979-A57A-B467B10B0DFBQ33899641-8CF5CD42-3399-43BC-BF86-C823058EC5F1Q33934080-79965802-9C23-4CFF-9E4E-BB2142DE5343Q34315579-CDDB5454-49ED-4904-BA6E-4E0C27C4DF6AQ34361901-8FC7487D-C2B0-4096-91E9-B66117532ABDQ34412603-D658A09D-0E6A-4A65-9DE8-3C37E9905E4EQ34784783-EC1F0248-A11B-47EB-8762-3DFE7E1BD570Q34979474-9A6FFBA3-F61A-4E80-B965-E0CFF98290FDQ35064091-965161E8-514A-43C7-8E73-271ABBA159A3Q35493901-4DC760D2-AC63-4D9C-BC8E-909A8157131CQ35935297-4CBA2279-83A1-4D03-A0E8-2688D849A7FFQ36440262-F34CCD4B-A61C-4EB1-B2B3-49F6077F3569Q36601953-3A662601-F2D7-437E-A652-DF094D85FF63Q36671999-714DFEE4-489A-4509-A78B-19ACDA32E4C8Q36957752-9918A221-8F0B-4932-9DC7-A4914FC1C427Q37038775-46F67F5C-DE6A-4C63-A15F-516E0B4A71B2Q37250180-1024B0CC-8254-4FA5-BB75-9975D06B0233Q37556442-82E2CA92-25D4-4BCC-ADBC-5AF088522DA4Q38152430-4B6F0EF8-C8D1-4399-8DEC-C88A4B027899Q38177684-2345D919-36EA-40C1-94E3-FFD310C1B5D1Q38261508-55B419F6-4FE5-4444-9CDA-FE4F7EB8444CQ38840473-D0AA8917-2D9D-4C82-B4A4-43F34BA3AA13Q38851822-D5F53556-FA45-4BA4-8298-97369FBF38FEQ39392100-B05B378F-6173-4612-9346-FD89604170B9Q39540038-770C6BE0-FA0B-48B5-A0CF-FD88C89047D9Q40140188-970D7294-0122-4B60-B78A-EA770274AF70Q40332270-F2378618-9FF3-4C0F-9D5D-124BB64E07C3Q40779840-0C9FC209-B40D-4EE8-A404-4118A707A7A3Q42202541-F88D3999-E335-4DBA-BE99-BAD3E1792257Q42238390-1195AD5A-E5DF-4E2B-97C2-15B7CDFA6C24Q46350318-98761DF9-7242-45EB-B461-51D663D106E9Q55512254-06D710DD-68D8-4BDF-908E-8558D3C6C0DA
P2860
T-cell phenotypes, apoptosis and inflammation in HIV+ patients on virologically effective cART with early atherosclerosis
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
T-cell phenotypes, apoptosis a ...... ART with early atherosclerosis
@ast
T-cell phenotypes, apoptosis a ...... ART with early atherosclerosis
@en
T-cell phenotypes, apoptosis a ...... ART with early atherosclerosis
@nl
type
label
T-cell phenotypes, apoptosis a ...... ART with early atherosclerosis
@ast
T-cell phenotypes, apoptosis a ...... ART with early atherosclerosis
@en
T-cell phenotypes, apoptosis a ...... ART with early atherosclerosis
@nl
prefLabel
T-cell phenotypes, apoptosis a ...... ART with early atherosclerosis
@ast
T-cell phenotypes, apoptosis a ...... ART with early atherosclerosis
@en
T-cell phenotypes, apoptosis a ...... ART with early atherosclerosis
@nl
P2093
P2860
P50
P1433
P1476
T-cell phenotypes, apoptosis a ...... ART with early atherosclerosis
@en
P2093
Antonella D'Arminio Monforte
Elisa Suardi
Esther Merlini
Francesca Bai
Gian Vico Melzi D'Eril
Javier Sánchez Martínez
Maddalena Cerrone
P2860
P304
P356
10.1371/JOURNAL.PONE.0046073
P407
P577
2012-09-27T00:00:00Z